• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS; TORIC IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS; TORIC IOLS Back to Search Results
Model Number ZCT225
Medical Device Problem Code Unintended Movement (3026)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Impairment (2138); No Code Available (3191)
Date of Event 04/10/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If explanted; give date: not applicable, the lens remains implanted.(b)(4).All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
A report was received from a patient stating that he had surgery yesterday on his right eye ((b)(6) 2018) and is not happy with outcome.The patient says he can¿t see out of his eye and is not comfortable with his doctor¿s information that was given.In follow-up with the patient it was learnt that on the day of his surgery his vision looked cloudy and the day after surgery his vision was blurry.During the follow-up visit with his surgeon, he was informed that the lens dislocated.He has another follow up visit scheduled for (b)(6) 2018 to his doctor to see if the lens has re-positioned itself.He then has another appointment scheduled on (b)(6) 2018 to reposition the lens if the lens remains dislocated.No additional information provided.
 
Additional Manufacturer Narrative
Device evaluation: the product testing could not be performed as the product was not returned.The reported complaint cannot be confirmed.Manufacturing record review: the manufacturing process record was evaluated and no deviation was found during process related to the complaint issue reported.There was no discrepancy found during the mrr (manufacturing record review).The product was manufactured and released according to specifications.A search revealed that no similar complaints were received for this production order.Labeling review: the directions for use (dfu) was reviewed.The dfu adequately provides instructions and precautions for the proper use and handling of the product.Conclusion: based on the investigation results there is no indication of a product quality deficiency.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TECNIS
Common Device Name
TORIC IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
santa ana CA 92705
MDR Report Key7505609
Report Number9614546-2018-00454
Device Sequence Number13809148
Product Code HQL
UDI-Device Identifier05050474552760
UDI-Public(01)05050474552760(17)210227
Combination Product (Y/N)Y
Initial Reporter CountryUS
PMA/510(K) Number
P980040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Patient
Type of Report Initial,Followup
Report Date (Section B) 09/10/2018
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Physician
Device Expiration Date02/27/2021
Device Model NumberZCT225
Device Catalogue NumberZCT225U215
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 04/11/2018
Supplement Date Received by Manufacturer08/17/2018
Initial Report FDA Received Date05/10/2018
Supplement Report FDA Received Date09/10/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age85 YR
Date Report Sent to FDA01/01/2005
-
-